LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$65.46 USD
+2.47 (3.92%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $65.45 -0.01 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth D Momentum D VGM
Brokerage Reports
0 items in cart
LeMaitre Vascular, Inc. [LMAT]
Reports for Purchase
Showing records 81 - 100 ( 188 total )
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Inaugural KBCM Life Sciences & MedTech Forum: Day 2 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
4Q20 Recap - Strong Execution at Premium Valuation
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
3Q19 Recap - Solid Results; Waiting on Entry Point
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S